Dynamics of Health Care Financing and Spending in Serbia in the XXI Century
暂无分享,去创建一个
M. Jakovljevic | V. Reshetnikov | S. Bolevich | Y. Timofeyev | Katarina M. Janicijevic | Kristijan Krstic | E. Arsentyev | Gvozden Rosic | S. Bolevich | Gvozden Rosić
[1] R. Ádány,et al. Comparative financing analysis and political economy of noncommunicable diseases , 2019, Journal of medical economics.
[2] V. Reshetnikov,et al. To the biography of N.A. Semashko: on the work of the first People’s Commissar of Health in 1920–1925 , 2018 .
[3] M. Jakovljevic,et al. Cold War Legacy in Public and Private Health Spending in Europe , 2018, Frontiers in Public Health.
[4] R. Ádány,et al. Population aging and migration – history and UN forecasts in the EU-28 and its east and south near neighborhood – one century perspective 1950–2050 , 2018, Globalization and Health.
[5] M. Jakovljevic,et al. Evolving Health Expenditure Landscape of the BRICS Nations and Projections to 2025. , 2017, Health economics.
[6] E. Varavikova,et al. Alcohol Beverage Household Expenditure, Taxation and Government Revenues in Broader European WHO Region , 2017, Front. Pharmacol..
[7] G. W. Wolf,et al. Socio-Economic Inequalities, Out-of-Pocket Payment and Consumers' Satisfaction with Primary Health Care: Data from the National Adult Consumers' Satisfaction Survey in Serbia 2009–2015 , 2017, Front. Pharmacol..
[8] M. Jakovljevic,et al. Within the triangle of healthcare legacies: comparing the performance of South-Eastern European health systems , 2017, Journal of medical economics.
[9] V. Vasić,et al. Do health care workforce, population, and service provision significantly contribute to the total health expenditure? An econometric analysis of Serbia , 2016, Human Resources for Health.
[10] M. Jakovljevic,et al. Life expectancy and health expenditure evolution in Eastern Europe—DiD and DEA analysis , 2016, Expert review of pharmacoeconomics & outcomes research.
[11] B. Łyszczarz. PUBLIC-PRIVATE MIX AND PERFORMANCE OF HEALTH CARE SYSTEMS IN CEE AND CIS COUNTRIES , 2016 .
[12] M. Jakovljevic,et al. Self-Assessed Health and Socioeconomic Inequalities in Serbia: Data from 2013 National Health Survey , 2016, Front. Pharmacol..
[13] M. Jakovljevic,et al. Review of Diagnosis-Related Group-Based Financing of Hospital Care , 2016, Health services research and managerial epidemiology.
[14] M. Jakovljevic,et al. The New and Old Europe: East-West Split in Pharmaceutical Spending , 2016, Front. Pharmacol..
[15] M. Jakovljevic. The aging of Europe. The unexplored potential , 2015 .
[16] M. Jakovljevic,et al. Population Aging from 1950 to 2010 in Seventeen Transitional Countries in the Wider Region of South Eastern Europe , 2015, South Eastern European Journal of Public Health.
[17] W. Groot,et al. Out-of-pocket payments for health care in Serbia. , 2015, Health policy.
[18] S. Janković,et al. Evolution of the Serbian pharmaceutical market alongside socioeconomic transition , 2015, Expert review of pharmacoeconomics & outcomes research.
[19] M. Jakovljevic,et al. Growing Burden of Non-Communicable Diseases in the Emerging Health Markets: The Case of BRICS , 2015, Front. Public Health.
[20] M. Jakovljevic,et al. End-of-life costs of medical care for advanced stage cancer patients. , 2015, Vojnosanitetski pregled.
[21] Raisa Fedosova,et al. Формы Участия Государства, Негосударственного и Частного Секторов в Реализации Социальной Политики (Features of the Ratio of Government, Non-Government and Private Sectors in the Framework of the Corporate Social Responsibility) , 2015 .
[22] A. Dagović,et al. Macroeconomic Policy Impact On Oncology-Related Public Expenditure In An Emerging European Market – Signs Of Early Recovery , 2015 .
[23] A. Dagović,et al. Resource use and costs of newly diagnosed cancer initial medical care , 2015 .
[24] M. Jakovljevic,et al. Community-acquired pneumonia: economics of inpatient medical care vis-à-vis clinical severity*,** , 2015, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.
[25] M. Jakovljevic,et al. Accessibility and Affordability of Alcohol Dependency Medical Care in Serbia , 2015, Front. Psychiatry.
[26] A. Dagović,et al. Radiation therapy remains the key cost driver of oncology inpatient treatment , 2015, Journal of medical economics.
[27] M. Jakovljevic,et al. Health Financing Constrained by Population Aging - An Opportunity to Learn from Japanese Experience / Finansiranje Zdravstvene Zaštite U Uslovima Starenja Popualcije - Prilika Da Učimo Na Japanskom Iskustvu , 2014 .
[28] S. Stošić,et al. Health care economics in Serbia: current problems and changes. , 2014, Vojnosanitetski pregled.
[29] A. Dagović,et al. Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin's lymphoma. , 2014, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.
[30] M. Jakovljevic. The Key Role of the Leading Emerging Bric Markets in the Future of Global Health Care , 2014 .
[31] M. Jakovljevic. Oncology monoclonal antibodies expenditure trends and reimbursement projections in the emerging Balkan market , 2014 .
[32] Tamara Rađenović,et al. The Effectiveness of Monetary and Fiscal Policy in Serbia , 2013 .
[33] M. Jakovljevic,et al. Radiology Services Costs and Utilization Patterns Estimates in Southeastern Europe-A Retrospective Analysis from Serbia. , 2013, Value in health regional issues.
[34] Z. Čekerevac,et al. HEALTH INSURANCE SYSTEM IN SERBIA – QUALITY, REFORM, FINANCIAL SUSTAINABILITY , 2013 .
[35] Vladimir Zivković,et al. The effects of a new traffic safety law in the Republic of Serbia on driving under the influence of alcohol. , 2013, Accident; analysis and prevention.
[36] M. Jakovljevic,et al. Resource allocation strategies in Southeastern European health policy , 2013, The European Journal of Health Economics.
[37] K. Henke,et al. The German Central Health Fund-recent developments in health care financing in Germany. , 2013, Health policy.
[38] W. Groot,et al. Measuring the catastrophic and impoverishing effect of household health care spending in Serbia. , 2013, Social science & medicine.
[39] M. Jakovljevic,et al. Current Efforts and Proposals to Reduce Healthcare Costs in Serbia , 2011 .
[40] Naoki Ikegami,et al. Japanese universal health coverage: evolution, achievements, and challenges , 2011, The Lancet.
[41] W. Bartlett,et al. The political economy of decentralisation and regional policy in Serbia: choices and outcomes , 2011 .
[42] D. Radojkovic,et al. Healthcare in Serbia in transition period , 2010, EPMA Journal.
[43] M. Milicevic,et al. Hospital management training and improvement in managerial skills: Serbian experience. , 2010, Health policy.
[44] Vesna Lukić,et al. Could Refugees Have a Significant Impact on the Future Demographic Change of Serbia , 2010 .
[45] K. Maiese. Choices and outcomes , 2009, Oxidative medicine and cellular longevity.
[46] J. Straussman. An Essay on the Meaning(s) of “Capacity Building”—With an Application to Serbia , 2007 .
[47] D. Lecic Tosevski,et al. Reform of mental health care in Serbia: ten steps plus one. , 2007, World psychiatry : official journal of the World Psychiatric Association.
[48] M. Mccarthy. Serbia rebuilds and reforms its health-care system , 2007, The Lancet.
[49] D. L. Kennedy,et al. Innovation in Medical Technology: Ethical Issues and Challenges , 2007 .
[50] J. Nemec,et al. Market-based health care reforms in Central and Eastern Europe: lessons after ten years of change , 2006 .
[51] S. Draganić-Gajić,et al. The Serbian Experience , 2005 .
[52] M. Vanrooyen,et al. Integrating quantitative and qualitative methodologies for the assessment of health care systems: emergency medicine in post-conflict Serbia , 2005, BMC health services research.
[53] W. Gerth,et al. Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge? , 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[54] J. Dragović-Soso. Rethinking Yugoslavia: Serbian Intellectuals and the ‘National Question’ in Historical Perspective , 2004, Contemporary European History.
[55] S. Janković,et al. Public drug procurement: the lessons from a drug tender in a teaching hospital of a transition country , 2004, European Journal of Clinical Pharmacology.
[56] Ronald Lee,et al. The Demographic Transition: Three Centuries of Fundamental Change , 2003 .
[57] M. Vanrooyen,et al. Multimodal Assessment of the Primary Healthcare System of Serbia: A Model for Evaluating Post-Conflict Health Systems , 2003, Prehospital and Disaster Medicine.
[58] John H. Reif,et al. Successes and challenges , 2021, Strategic Community Partnerships, Philanthropy, and Nongovernmental Organization.
[59] W. Nordhaus,et al. The Health of Nations: The Contribution of Improved Health to Living Standards , 2002 .
[60] David Canning,et al. The Health and Wealth of Nations , 2000, Science.
[61] W. Cole Durham,et al. Organization for Security and Co-Operation in Europe: Lisbon Document 1996 , 1997, International Legal Materials.
[62] Marko Šuica. Serbia , 2019, The Palgrave Handbook of Conflict and History Education in the Post-Cold War Era.
[63] M. Jakovljevic,et al. Gender-Specific Health-Seeking Behavior and Income Status among the Elderly Citizens of Serbia , 2017 .
[64] M. Jakovljevic. Population ageing alongside health care spending growth , 2017 .
[65] M. Arsic,et al. Fiscal reaction to interest payments: The case of Serbia , 2016 .
[66] M. Jakovljevic,et al. Long Term Health Spending Alongside Population Aging in N-11 Emerging Nations , 2016 .
[67] M. Arsic,et al. PUBLIC DEBT SUSTAINABILITY IN SERBIA BEFORE AND DURING THE GLOBAL FINANCIAL CRISIS , 2016 .
[68] M. Jakovljevic,et al. Do Health Reforms Impact Cost Consciousness of Health Care Professionals? Results from a Nation-Wide Survey in the Balkans. , 2016, Balkan medical journal.
[69] S. Janković,et al. Cost-effectiveness of depressive episode pharmacological treatment , 2015 .
[70] M. Jakovljevic. Health Expenditure Dynamics in Serbia 1995-2012 , 2014 .
[71] N. Bontis,et al. Intellectual Capital and Financial Performance in Serbia , 2013 .
[72] Jasna Petrić,et al. The population conundrums and some implications for urban development in Serbia , 2012 .
[73] Jelena Stojilković. Growing number of pensioners and population aging in Serbia , 2011 .
[74] Dejan Milenkovic,et al. Applying electronic documents in development of the healthcare information system in the Republic of Serbia , 2009, Comput. Sci. Inf. Syst..
[75] Marta Borda,et al. THE ROLE OF PRIVATE HEALTH CARE FINANCING IN THE CENTRAL AND EASTERN EUROPEAN COUNTRIES , 2008 .
[76] D. Lecic Tosevski,et al. Reform of mental health care in Serbia: ten steps plus one. , 2007, World psychiatry : official journal of the World Psychiatric Association.
[77] E. Tompa. The Impact of Health on Productivity : Empirical Evidence and Policy Implications Emile Tompa , 2002 .
[78] P. Musgrove. Health insurance: the influence of the Beveridge Report. , 2000, Bulletin of the World Health Organization.